DS
HALO icon

DRW Securities’s Halozyme HALO Stock Holding History

DRW Securities’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
+2,824
New +$193K 0.01% 754
2026
Q1 		– Sell
-3,422
Closed -$230K – 1481
2025
Q4 		$230K Buy
+3,422
New +$230K 0.01% 857

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

DRW Securities's HALO Position: Q2 2026 in Review

DRW Securities opened a new position in Halozyme (HALO) in Q2 2026: 2,824 shares worth $221K. The stake represents 0.01% of the portfolio and ranks #754 among its holdings. This is a return to the name: DRW Securities previously reported a position in HALO as recently as Q4 2025.

DRW Securities first reported a position in HALO in Q4 2025 and has held it in 2 quarters since. The position peaked at $230K in Q4 2025. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • DRW Securities held 2,824 shares of Halozyme worth $221K as of Q2 2026.
  • Halozyme was a new DRW Securities position in Q2 2026.
  • Halozyme made up 0.01% of DRW Securities's portfolio in Q2 2026, its #754 holding.
  • DRW Securities first reported a position in Halozyme in Q4 2025 and has held it in 2 quarters since.
  • DRW Securities's Halozyme position peaked at $230K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.